Schwab Andrew J.

CIK 1598549
Transactions on file
40

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-09-242026-09-23SKYE
Skye Bioscience, Inc.
Sale4,528$7.3K+3.7%open →
2026-09-242026-09-23SKYE
Skye Bioscience, Inc.
Sale114,851$184.9K+3.7%open →
2026-09-242026-09-22SKYE
Skye Bioscience, Inc.
Sale1,088$1.8K+1.2%open →
2026-09-242026-09-22SKYE
Skye Bioscience, Inc.
Sale27,612$45.6K+1.2%open →
2026-09-182026-09-16SKYE
Skye Bioscience, Inc.
Sale1,285$2.5K-12.6%open →
2026-09-182026-09-16SKYE
Skye Bioscience, Inc.
Sale32,607$62.3K-12.6%open →
2026-08-312026-08-27CAMP
Camp4 Therapeutics Corp
Sale400,000$1.62M-5.0%open →
2026-08-262026-08-24CAMP
Camp4 Therapeutics Corp
Sale10$45.00-14.7%open →
2026-08-222026-08-21CAMP
Camp4 Therapeutics Corp
Sale32,018$144.1K-14.7%open →
2026-08-222026-08-20CAMP
Camp4 Therapeutics Corp
Sale114,700$520.7K-15.4%open →
2026-08-222026-08-19CAMP
Camp4 Therapeutics Corp
Sale45,147$214.9K-19.3%open →
2026-08-212026-08-20SKYE
Skye Bioscience, Inc.
Sale6,495$2.1K+421.9%open →
2026-08-212026-08-20SKYE
Skye Bioscience, Inc.
Sale46$14.72+421.9%open →
2026-08-212026-08-20SKYE
Skye Bioscience, Inc.
Sale1,159$370.88+421.9%open →
2026-08-212026-08-19SKYE
Skye Bioscience, Inc.
Sale57,476$20.1K+377.1%open →
2026-08-212026-08-19SKYE
Skye Bioscience, Inc.
Sale409$143.15+377.1%open →
2026-08-212026-08-19SKYE
Skye Bioscience, Inc.
Sale10,255$3.6K+377.1%open →
2026-08-212026-08-18SKYE
Skye Bioscience, Inc.
Sale253,080$96.2K+339.5%open →
2026-08-212026-08-18SKYE
Skye Bioscience, Inc.
Sale1,830$695.40+339.5%open →
2026-08-212026-08-18SKYE
Skye Bioscience, Inc.
Sale45,090$17.1K+339.5%open →
2026-08-122026-08-10LTGO
Latigo Biotherapeutics, Inc.
10%
C2,350,419$0.00—open →
2026-08-122026-08-10LTGO
Latigo Biotherapeutics, Inc.
10%
C4,975,543$0.00—open →
2026-08-102026-08-07TRDA
Entrada Therapeutics, Inc.
10%
Sale52,317$358.4K-9.2%open →
2026-08-102026-08-06TRDA
Entrada Therapeutics, Inc.
10%
Sale10,494$73.5K-11.1%open →
2026-08-032026-07-31TRDA
Entrada Therapeutics, Inc.
10%
Sale1,718$11.8K-9.2%open →
2026-08-032026-07-30TRDA
Entrada Therapeutics, Inc.
10%
Sale114,756$795.3K-10.2%open →
2025-11-182025-11-14TRDA
Entrada Therapeutics, Inc.
10%
Sale200,000$1.76M-29.3%open →
2025-07-012025-06-30TRDA
Entrada Therapeutics, Inc.
10%
Sale6,422$43.7K-8.7%open →
2025-07-012025-06-30TRDA
Entrada Therapeutics, Inc.
10%
Sale18,578$126.5K-8.7%open →
2025-07-012025-06-27TRDA
Entrada Therapeutics, Inc.
10%
Sale19,265$133.1K-10.0%open →
2025-07-012025-06-27TRDA
Entrada Therapeutics, Inc.
10%
Sale55,735$385.1K-10.0%open →
2025-07-012025-07-01TRDA
Entrada Therapeutics, Inc.
10%
Sale18,578$132.3K-12.6%open →
2025-07-012025-07-01TRDA
Entrada Therapeutics, Inc.
10%
Sale6,422$45.7K-12.6%open →
2025-07-112025-07-09TRDA
Entrada Therapeutics, Inc.
10%
Sale6,935$52.0K-17.1%open →
2025-07-112025-07-09TRDA
Entrada Therapeutics, Inc.
10%
Sale20,065$150.5K-17.1%open →
2025-08-222025-08-21SKYE
Skye Bioscience, Inc.
Director10%
Sale2,314$8.3K-53.2%open →
2025-08-222025-08-21SKYE
Skye Bioscience, Inc.
Director10%
Sale58,642$209.4K-53.2%open →
2025-08-222025-08-22SKYE
Skye Bioscience, Inc.
Director10%
Sale163,979$560.8K-51.2%open →
2025-08-222025-08-22SKYE
Skye Bioscience, Inc.
Director10%
Sale6,470$22.1K-51.2%open →
2025-09-152025-09-11CAMP
Camp4 Therapeutics Corp
Director10%
Grant2,941,176$4.50M+151.0%open →